Durgam, S.
85  results:
Search for persons X
?
5

P.0424 Adjunctive lumateperone (ITI-007) in the treatment o..:

Yatham, L. ; Durgam, S. ; Kozauer, S....
European Neuropsychopharmacology.  53 (2021)  - p. S308-S309 , 2021
 
?
6

P.0420 The efficacy of lumateperone in patients with bipola..:

McIntyre, R. ; Durgam, S. ; Huo, J...
European Neuropsychopharmacology.  53 (2021)  - p. S305 , 2021
 
?
7

P.468 Cardiometabolic safety of lumateperone (ITI-007): pos..:

Satlin, A. ; Durgam, S. ; Vanover, K.E....
European Neuropsychopharmacology.  40 (2020)  - p. S265-S266 , 2020
 
?
8

P.446 Efficacy and safety of lumateperone (ITI-007) in the ..:

Durgam, S. ; Satlin, A. ; Vanover, K.E....
European Neuropsychopharmacology.  40 (2020)  - p. S253-S254 , 2020
 
?
9

P.673 Results from a 12-month open-label safety study of lu..:

Correll, C.U. ; Vanover, K.E. ; Durgam, S....
European Neuropsychopharmacology.  29 (2019)  - p. S455-S456 , 2019
 
?
10

P.671 Efficacy and safety of lumateperone tosylate 42mg in ..:

Kane, J.M. ; Vanover, K.E. ; Durgam, S....
European Neuropsychopharmacology.  29 (2019)  - p. S453-S454 , 2019
 
?
 
?
12

Sustained remission with cariprazine treatment: post hoc an..:

Correll, C.U. ; Potkin, S.G. ; Durgam, S....
European Neuropsychopharmacology.  27 (2017)  - p. S935-S936 , 2017
 
?
13

Efficacy of cariprazine in subgroups of bipolar patients wi..:

Vieta, E. ; Durgam, S. ; Lu, K....
European Neuropsychopharmacology.  27 (2017)  - p. S936-S937 , 2017
 
?
14

Efficacy of cariprazine on predominant negative symptoms of..:

Marder, S. ; Laszlovszky, I. ; Szalai, E....
European Neuropsychopharmacology.  26 (2016)  - p. S550 , 2016
 
?
15

Efficacy of cariprazine in negative, cognitive, and social ..:

Cutler, A.J. ; Durgam, S. ; Lu, K....
European Neuropsychopharmacology.  26 (2016)  - p. S551-S552 , 2016
 
1-15